Safety and tolerability of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis: a multicenter, double-blind, placebo controlled randomized clinical trial.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Rifaximin (Primary) ; Simvastatin (Primary)
- Indications Liver cirrhosis
- Focus Adverse reactions
- Acronyms LIVERHOPE
- 19 Mar 2018 This trial has been completed in Spain, according to European Clinical Trials Database.
- 06 Mar 2018 Planned End Date changed from 10 Dec 2017 to 1 Mar 2018.
- 06 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.